Frailty is a predictor of adverse health outcomes and can be measured across the life course, including among people living with HIV. The purpose of this study was to examine two commonly used measures of frailty -the frailty index (FI) and frailty phenotype -to assess common characteristics and to describe associations with multimorbidity, falls, and disability in people aging with HIV.
Introduction
Frailty is conceptualized as a condition of increased risk for poor resolution of homeostasis after a stressor event, resulting from cumulative decline across multiple physiological systems [1] . Frailty is a predictor of poor prognosis, including increased risk of falls, dementia, delirium, institutionalization, and death. While commonly associated with advanced age, frailty can be measured across the life course [2] , including among people living with HIV [3] .
Multiple approaches have been used to operationalize frailty, and how to best do so in clinical and research settings remains controversial [4] . Frailty can be thought of as a specific clinical syndrome, characterized by diminished strength and endurance, and reduced physiological function. The most commonly used measure applying this syndromic approach is the frailty phenotype, which assesses five specific features: self-reported weight loss, self-reported exhaustion, low levels of physical activity as measured by a standardized questionnaire, measured 4 meters walking time, and measured grip strength [5] . Frailty can also be considered a risk state, associated with the accumulation of multiple multisystem health deficits, including comorbidities and disabilities. The most commonly used measure applying this cumulative deficits approach is the frailty index (FI). An FI is calculated as the proportion of health deficits an individual has out of at least 30 assessed health variables, which can include signs or symptoms, diagnoses, impairments, or laboratory abnormalities [6] . This information can come from a range of data sources, including the results of a comprehensive geriatric assessment. Importantly, the specific deficits included in the index can vary according to the available data.
It is not uncommon for a clinician or researcher to have a preference for one or the other approach to frailty measurement. However, it may be inappropriate to consider the frailty phenotype and the FI as alternatives and/or substitutable. Instead, efforts to understand the potential complementarity of, and differences between, the two approaches represent a useful area of inquiry.
Both the frailty phenotype [7] and FI [8] approaches have been applied in the HIV setting, demonstrating an age-related state of vulnerability to adverse outcomes in terms of survival and incident multimorbidity, independent of HIV disease-severity markers. To date, no studies have compared these two tools in the same HIV-infected cohort, including examining their relationship with adverse health outcomes.
The objectives were two-fold: first, to examine whether the FI and frailty phenotype demonstrate common characteristics in terms of distribution, sex differences in frailty scores, relationship of frailty with age, and prevalence of frailty; secondly, to describe their associations with clinically relevant outcomes including multimorbidity, falls, and disability, after adjustment for HIV characteristics and demographic factors.
Methods

Setting and sample
This was a cross-sectional observational study including consecutive HIV patients attending the multidisciplinary metabolic clinic at the University of Modena and Reggio Emilia School of Medicine in Modena, Italy (MHMC) in the period January 2015 to June 2016. Patients were evaluated for frailty status as part of the routine MHMC protocol.
Frailty phenotype
The frailty phenotype is based on a predefined set of five criteria exploring the presence/absence of signs or symptoms (involuntary weight loss, exhaustion, slow gait speed, poor handgrip strength, and sedentary behaviour). The number of criteria (a six-level ordinal variable ranging from 0 to 5) is categorized as a three-level variable depicting robustness (meets none of the criteria), prefrailty (meets one or two criteria) and frailty (meets three or more criteria) [5] .
• Involuntary weight loss was assessed as a reduction of > 5% of body weight in the last year.
• Exhaustion was measured by a questionnaire enquiring: How often in the last week did you feel this way? (a) I felt that everything I did was an effort; (b) I could not get going. Possible responses were: a moderate amount of the time (3-4 days) or most of the time = 1; rarely or none of the time (< 1 day) or some or a little of the time (1-2 days) = 0.
• Gait speed was measured by a 15ft walking test. A deficit was assigned according to the following gender- • Handgrip strength was measured by a grip strength test using the dominant hand (Digital Smedley Spring Hand Dynamometer, Fabrication Enterprise, White Plains, NY, USA; average score in three trials). Deficit was assigned according to the following gender-specific criteria [adjusted by sex and body mass index (BMI) quartile using CHS population cut off suggested by • Physical inactivity was assessed with the Minnesota Leisure Time Activity Questionnaire, which asks about difficulty doing activities such as: walking, chores (moderately strenuous), mowing the lawn, raking, gardening, hiking, jogging, biking, exercise cycling, dancing, aerobics, bowling, golf, singles tennis, doubles tennis, racquetball, calisthenics, and swimming over the past 2 weeks. Possible responses were: 'no difficulties', 'some difficulty' and 'much difficulty'.
Frailty index
An FI was constructed from 37 health variables collected at the same study visit (Table S1 ), as previously described (Guaraldi AIDS 2015) . Each variable included in the FI was coded with a value of 1 when a deficit was present and 0 when it was absent (18) . Missing values were removed from both the numerator and the denominator of the FI:
A study visit could be used for FI evaluation if patients had measurements available for ≥ 80% of health variables at that visit (12) . The FI score for each patient visit is embedded in the electronic health record of the MHMC, serving as a reference for subsequent assessments. Of note, the health variables that were selected as outcomes or covariates of interest (e.g. comorbidities) for this study were excluded as items from the FI. In other settings (e.g. clinical practice), these variables could be incorporated into the FI.
The FI is meant to be used as a continuous score; however, in order to compare it with the phenotype, it was also categorized based on proposed cut points identified using stratum-specific likelihood ratios [9] : FI ≤ 0.10 was considered 'nonfrail', 0.10 < FI ≤ 0.21 was 'vulnerable', 0.21 < FI ≤ 0.45 was 'frail,' and FI > 0.45 was 'most frail'.
Multimorbidity, falls and disability
Multimorbidity was defined as at least three comorbid conditions occurring in the same individual, including: hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease (COPD), chronic kidney disease, osteoporosis, liver cirrhosis and cancers [10] .
Falls were assessed according to a standardized falls history questionnaire asking about falls in the past 6 months. The presence of any falls in this time period was considered a positive score [11] .
Disability was assessed using Instrumental Activities of Daily Living (IADL), an eight-item questionnaire which measures the ability to use the telephone, engage in food preparation, shopping, housekeeping and laundry, use transportation, take responsibility for medications, and handle finances. For each question, there were three possible responses and the scoring for each response was: independent, three points; any assistance needed, two points; totally dependent, 1 point [12] . The presence of any assistance in daily living was considered a positive score.
Covariates
Demographic and lifestyle factors of interest included age, sex, smoking status and, for smokers, tobacco exposure (measured as pack-years). HIV characteristics evaluated included HIV infection and antiretroviral therapy (ART) durations, and nadir and current CD4 counts.
Ethics
Approval for the Modena HIV Metabolic Clinic Cohort was obtained from the Research Ethics Board of the University of Modena and Reggio Emilia, and all participants provided written consent.
Statistical analysis
Descriptive statistics, frailty phenotype categories and FI scores at first visit were calculated and distributions were plotted. We assessed the frequency of frailty phenotype categories and the mean and standard deviation of FI for the sample.
We used adjusted multivariate logistic regressions models to examine the association between frailty (as measured by both the FI and the frailty phenotype) and each of the following binary outcomes: multimorbidity, falls, and disability.
Results
A total of 482 participants were evaluated for frailty using both the frailty phenotype and the FI. Participants had a mean age of 53.9 years, and three-quarters were male. Table 1 describes the demographic and clinical characteristics of the cohort.
As classified by the frailty phenotype categories, 3.1% (15) of participants were considered to be frail, 51.9% (250) were pre-frail, and 45.0% (217) were robust. The mean value of FI score was 0.28 AE 0.1, which translates into an average of 11 deficits out of the total of 37 possible deficits.
The distribution of scores on both frailty scales, measured as an index, resembled a distribution with a long right tail.
For those categorized as robust or pre-frail according to the frailty phenotype, the corresponding mean FI was 0.3. For those categorized as frail, the corresponding mean FI was 0.4 ( Fig. 1) . The proportion of participants in each category of the FI and frailty phenotype is shown in Table 2 . Table 3 shows the relationship of frailty with HIV variables for both the FI (a) and the frailty phenotype (b).
Whereas there were no statistically significant differences noted in comorbidities and multimorbidity between robust, pre-frail and frail categories of the frailty phenotype, statistically significant differences were noted across the FI categories (Fig. 2) .
The FI but not the frailty phenotype was associated with falls and disability. Figure 3 shows the association between falls history and IADL impairment and the proportion of frail patients (FI and frailty phenotype); this figure also shows logistic regression analyses for the prediction of falls and IADL and FI and FP, respectively, after correction for age and gender.
Discussion
This study describes the MHMC experience in assessing frailty phenotype and FI as part of routine clinical evaluation in patients at a tertiary-level HIV clinic. These frailty measures may depict different domains of HIV disease, and we therefore propose that they should be considered as complementary in clinical and research settings.
The properties of both the FI and the modified frailty phenotype were consistent with previously accepted characteristics of other frailty measures [13, 14] , including the right-skewed distribution of frailty and an increase with age. BMI, body mass index; APO, apolipoprotein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; COPD, chronic obstructive pulmonary disease; CDC, Centers for Disease Control and Prevention; IDU, injecting drug user; MSM, men who have sex with men; SD, standard deviation.
In our study, there were no gender differences in the mean FI score but the classification of frailty levels based on the frailty phenotype was statistically significantly different in men and women; this difference was driven by the higher proportion of nonfrailty in female patients. These findings are different from those of previous studies which showed a higher prevalence of frailty in women both in the general population [15, 16] and in HIVinfected cohorts [7, 17, 18] . This difference could be related to the participant characteristics and merits further examination in future studies.
Overall, we found that the frailty phenotype and FI were modestly positively correlated.
The duration of ART was significantly different across levels of frailty as measured by both instruments, but current CD4 count was not significantly different and nadir CD4 count was only significantly different for the FI. Both frailty measures were associated with multimorbidity. The FI was associated with IADL impairment and fall history, whereas the frailty phenotype was not.
The objective of this study was to assess the utility of frailty as a clinical tool that can be incorporated in ongoing monitoring of HIV-infected patients, and that can be used to describe HIV-infected cohort characteristics or to define a clinically meaningful endpoint. The integration of these tools in clinical practice will be crucial for the development of interventions in age-related conditions (in particular, disability and functional decline) in older persons living with HIV [2] . To our knowledge, this is the first study to have assessed and compared the performances of the frailty phenotype and FI in the same HIVinfected cohort in relation to demographic and lifestyle factors, HIV history and comorbidities, and disability.
It was our intention not to make a direct comparison of the frailty phenotype and FI to identify the better frailty measure, but rather to identify performance differences in relation to clinically meaningful outcomes. In particular, the FI but not the frailty phenotype was found to be sensitive to nadir CD4 count, but neither of the frailty measurements was associated with current CD4 count. Previous studies of the relationship between the degree of frailty and CD4 count have produced varied results. Inverse relationships between current CD4 count and frailty have been identified among patients presenting for HIV care [8, [19] [20] [21] , people living with HIV in the community [22] , and HIV-positive cohorts of men who Fig. 1 Relationship between frailty phenotype categories and frailty index score. have sex with men [23, 24] , women [25] , and people who inject drugs [17] . Among studies of HIV-infected outpatients [7, 26] , HIV-positive injecting drug users [27] , and men who have sex with men [28], frail and nonfrail participants were similar in terms of age and current CD4 count, but differed in comorbid conditions, smoking status, and markers of immune activation and inflammation. Based on our results, it appears that the FI summarizes the burden of HIV disease in terms of immunological damage and comorbidity more accurately than the frailty phenotype. The FI is largely based on nosographically classified conditions and therefore may describe a risk profile closer to that measured by the clinician, and define a condition of vulnerability different from that isolated by the phenotype of frailty.
The cross-sectional nature of this study did not allow us to assess FI change over time to predict adverse events. A strength of the FI is its continuous nature, compared with Fig. 2 Association of the frailty index and frailty phenotype with each condition and multimorbidity. CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; MM, Multi-Morbidity.
the categorical nature of the frailty phenotype. Therefore, the FI approach can be used in clinical practice to choose the level of intensity of patient monitoring required, and potentially to measure the health resources needed on an individual basis, as well as contributing to pharmaco-economic evaluations. This study has some limitations intrinsic to its cross-sectional design and the lack of a non-HIV-infected control group. Given the poorly standardized definition of disability, we operationalized disability in terms of IADL. Even so, we believe that more objective tools to assess disability are needed in the research setting.
In conclusion, we found that the frailty phenotype and the FI demonstrated some similar characteristics but the FI had a stronger association with age, nadir CD4 count, comorbidities, falls, and disability. Fig. 3 Association of the frailty index and frailty phenotype with falls and Instrumental Activities of Daily Living (IADL) disability and logistic regression analyses after correction for age and gender. OR, odds ratio.
